Inherited erythromelalgia (IEM), caused by mutations in Nav1.7 channel is characterized by episodic neuropathic pain triggered especially by warm temperature. However, the mechanism underlying the temperature–dependent episodic attacks of IEM remains elusive. We investigated the electrophysiological effect of temperature changes on Nav1.7 channels with three different mutations, p.I136V, p. I848T, and p.V1316A, both in vitro and in vivo. In vitro biophysical studies of the mutant channels show consistent temperature-dependent enhancement of the relative resurgent currents if normalized to the transient currents, as well as temperature-dependent changes in the time to peak and the kinetics of decay of the resurgent currents, but no congruent temperature–dependent changes in steady–state parameters such as shift of activation/inactivation curves and changes of the absolute size of the window or resurgent currents. In vivo nerve excitability tests (NET) in IEM patients reveal the essentially normal indices of NET at a single stimulus. However, there are evident abnormalities if assessed with preconditioning pulses, such as the decrease of threshold elevation in hyperpolarizing threshold electrotonus (50–100 ms), the increase of inward rectification in current–voltage curve, and the increase of refractoriness at the interpulse interval of 2–6 ms in recovery cycle, probably also implicating derangements in temperature dependence of inactivation and of recovery from inactivation in the mutant channels. The pathogenesis of heat–enhanced pain in IEM could be attributed to deranged temperature dependence of Nav1.7 channels responsible for the genesis of resurgent currents.
Primary erythromelalgia or inherited erythromelalgia (IEM; OMIN 133020) is an autosomal dominant chronic neurological disorder caused by mutations in human SCN9A gene encoding α subunit of Nav1.7 channel, which is abundantly expressed in trigeminal, sympathetic, and dorsal root ganglion neurons1,2,3,4. IEM is clinically characterized by episodic excruciating burning pain and erythema in the limbs. The symptomatic aggravation is frequently evoked by warm stimuli and relieved by cooling5,6,7. The nature of episodic attack is not fully understood but could be responsible for the core symptomatic pathogenesis of IEM and might shed light on potential therapies for the excruciating clinical conditions.
The IEM–causing mutations are scattered throughout the whole Nav1.7 channel protein, resulting in different gating alterations including hyperpolarizing shift in the activation curve, slowed macroscopic deactivation kinetics, and an increase in sustained currents8,9,10. However, despite that pain is constantly exacerbated by local heat among different mutations, there are only very limited and incongruous data on the effect of temperature on channel gating. A previous study by Han et al. showed a similar hyperpolarizing shift of the steady–state activation curve with p.L858F mutation at either warmer or cooler temperatures11. From a small Taiwanese cohort of the IEM patients, three mutations of SCN9A gene, p.I136V, p.I848T, and p.V1316A have been identified7. The familial segregation for the p.I136V mutation was confirmed in a Taiwanese family12. Both p.I848T and p.V1316A mutations are from sporadic cases; but they recurred in IEM patients with different ethnic origin7,13,14,15. The frequencies from these mutant alleles are less than 0.01% and they are likely pathogenic. The p.I136V and p.V1316A mutations caused further hyperpolarizing shift in the activation curve at warmer temperature, whereas the p.I848T mutant channel showed a depolarizing shift. Thus, the core pathophysiologic mechanism for heat–induced pain in IEM could not be fully explained by changes in steady–state parameters.
Resurgent sodium currents were previously proposed to be unaltered in IEM-related mutations16. However, we have recently discovered a significantly increase and altered kinetics of resurgent current with p.V1316A mutation14. Also, the effect of temperature on gating kinetics of the Nav1.7 channel has not been fully characterized and may well contribute to the intriguing heat–enhanced pain exacerbation. In this study, we investigated the effect of temperature changes on the molecular behavior of the wild–type (WT) and different mutant Nav1.7 channels both in vitro and in vivo (with nerve excitability test, NET), endeavoring to identify the key pathophysiological elements responsible for the symptomatic pathogenesis of IEM. The in vitro biophysical studies demonstrate that the activation kinetics of resurgent currents are much slower at 15 °C than at 25 °C, and even more so if compared to that at 40 °C in the mutant Nav1.7 channels, but the temperature dependence is far less pronounced in the WT channels. Consistently, the IEM patients show increased refractoriness and reduced superexcitability in recovery cycle (RC), and reduced threshold elevation at late hyperpolarizing threshold electrotonus (TE), both implying abnormalities in the recovery from inactivation in Na+ channels. Moreover, these NET abnormalities are effectively ameliorated by local cooling. These findings indicate that deranged resurgent Na+ currents, which are consequences of deranged temperature dependence of the kinetics of relevant molecular transitions, play the major and crucial role in the pathogenesis of IEM.
Larger window currents in the mutant Nav1.7 channels
The activation and inactivation curves of the p.I136V, p.I848T, and p.V1316A mutant channels are negatively and positively shifted in the membrane potential axis, respectively (Fig. 1A,B). On the other hand, the slope of both gating curves is grossly unchanged or only minimally or negligibly changed by these mutations (Fig. 1B). Figure 1C shows a closer view of the product of the two curves at each voltage (i.e., −20, −40, −60, and −80 mV), presumably a measurement of the “window current” or the sustained currents at each voltage. The products at each voltage are always larger in each of the mutant than in the wild type (WT) channels. The increase of sustained currents in the mutant channels at more positive voltages could also be directly demonstrated through measurement of the late currents during a depolarizing pulse (Fig. 1D), and could potentially contribute to the neural hyperexcitability in IEM14.
Incongruent window current changes with increasing temperature from 15 °C to 40 °C
Since warmth usually induces the excruciating pain in IEM patients, we assessed the effects of temperature changes on the WT, p.I136V, p.I848T, and p.V1316A mutant channels (Fig. 2A,B). Note that the peak transient currents appear to be the largest at 25 °C, and are smaller at both 15 °C and 40 °C. Lowering the medium temperature to 15 °C causes a hyperpolarizing shift of the activation curve but a depolarizing shift of the inactivation curve in the p.I136V, p.I848T, and p.V1316A mutant channels if compared with the WT channel (Fig. 2C). On the other hand, an increase of ambient temperature to 40 °C causes a depolarizing shift of the activation curve in the p.I136V, and p.I848T mutant channels, but a hyperpolarizing shift in the p.V1316A mutant channel in comparison with the WT channel (Fig. 2D). Moreover, the inactivation curves of the p.I136V and p.I848T, but not the p.V1316A mutant channels are shifted in the depolarizing direction if compared with the WT channel (Fig. 2D). All the mutant channels therefore tend to produce even larger window currents than the WT channel, both in higher (40 °C) and lower (15 °C) temperatures if compared with 25 °C (Fig. 2E and Supplementary Data Fig. S1). Increased window or sustained currents, albeit a common feature of all the mutant channels, thus does not seem to play the cardinal role in the pathogenesis of IEM, which is characterized by marked symptomatic aggravation by warming but ameliorated by cooling. In this regard, it is interesting to note that the kinetics of macroscopic inactivation (the decay of the transient currents) are much slower in the mutant than in the WT channels at 15 °C but not at 40 °C (Supplementary Data Fig. S2), signaling a higher temperature dependence or “Q10” in the inactivation–related kinetics with IEM–causing mutations (see below).
Larger resurgent currents in the mutant Nav1.7 channel at 40 °C but not at 15 °C
We have shown that the resurgent currents are significantly larger at room temperature in the p.V1316A mutant channel than in the WT channel14. Consistently, the resurgent currents appear to be larger in all the three mutants than in the WT channel at 25 °C (Fig. 3A). On the othe hand, the absolute size of the resurgent currents seems to be the largest in 15 °C, apparently inconsistent with the relief of pain and reduced nerve excitability in IEM in low temperatures. However, a closer examination reveals that the normalized resurgent currents (Iresurgent) and the area under the resurgent current (Qresurgent) (normalized to the transient currents in the same cell) in all the mutant channels are most enhanced at 40 °C but least enhanced at 15 °C if compared with that in the WT channel (Fig. 3B–D and Supplementary Data Fig. S3). Because size of the resurgent currents is determined by the rates of entry to and exit from the resurgent open state14, we investigated changes in the kinetics of the resurgent currents in different temperatures. The decay gets faster at higher temperatures in all channels. However, the decay is always slower in the mutant channels, and such a difference is more prominent at higher temperatures (Fig. 3E–G). Also, the differences in time to peak between WT and the mutant channels are much larger at 40 °C than at 15 °C (Fig. 3H–J). We also examined the activation curve of resurgent currents and the kinetics of genesis of the inactivated states during the depolarization prepulse (which is indirectly related to the making of resurgent currents during the subsequent repolarization) in different temperatures for the WT and mutant channels. There is no congruent or consistent trend of changes in the activation curves of the WT, p.I136V, p.I848T, and p.V1316A mutant channels at 15 °C, 25 °C, and 40 °C (Supplementary Data Fig. S4). The resurgent current became smaller with lengthening of the depolarization prepulse in the WT and all mutant channels (Supplementary Data Fig. S5). The rate of decay was always slightly (~2–fold) slower in the three mutant channels than in the WT channel at both 15 °C and 25 °C at the same prepulse voltage. The steady–state relative residual resurgent currents, on the other hand, tend to be larger at more depolarized prepulse (e.g., +60 mV), and such a tendency also remains similar at 15 °C and 25 °C. These findings are consistent with the idea that the key pathophysiological factor for the symptomatic pathogenesis is the altered temperature dependence of the kinetics in the molecular transitions more directly responsible for the genesis of resurgent currents (e.g. transitions between the open and inactivated states, see Discussion).
Slower recovery from inactivation of the mutant than the WT Nav1.7 channels at 15 °C but not at 25 °C
The time to peak in Fig. 3 is a parameter closely related to the recovery kinetics from inactivation. Consistently, Fig. 4A,B show evident temperature–dependent changes in the kinetics of recovery from inactivation at −80 mV (a potential close to −60 mV, the voltage ranges for elicitation of resurgent currents in the previous figures). The recovery rates are similar for all channels at 25 °C. The recovery is markedly slowed at 15 °C, especially in the mutant channels (Fig. 4B,C). It is very difficult to get similar data at 40 °C because of the long–lasting duration of the experiments. Interestingly, the recovery rates are slowed to essentially the same level in the p.I136V, p.I848T, and p.V1316A mutant channels at 15 °C from the much more incongruent and faster values at 25 °C (Fig. 4B,C). On the other hand, the recovery rates are similar between the WT and the mutant channels at −120 mV either at 25 °C or 15 °C (Supplementary Data Fig. S6). The characteristic difference between the WT and the mutant channels at 15 °C but not at 25 °C is consistent with the idea that the key functional attribute responsible for the symptomatic pathogenesis of IEM lies in the direct making of resurgent currents, or more precisely, the processes involved in the recovery form inactivation of the channel (see Discussion).
Clinical correlation between the biophysical changes in mutant channels and sensory axonal excitability of IEM
To explore the clinical correlation of channel kinetic dysfunction, we investigated four patients (two males and two females; one female with p.I848T and the other three with p.I136V mutations) and 10 age– and gender–matched normal controls (five in each gender) with NET. The clinical profiles, medications and functional performances were shown in Supplementary Data Table 1. In the functional categories of SF–36 questionnaires, the patients reported a clear trend of limitations in physical function and in health related to pain in summer (ambient temperature 27.7–29.6 °C in Taiwan) than in winter (16.1–17.9 °C) (Supplementary Data Table 1). Consistently, the patients also reported that local cooling always relieved the pain. The NET findings are shown in Fig. 5 and Supplementary Data Table 1. There was no significant statistical difference in both resting threshold and rheobase (Fig. 5A,B) but strength–duration time constant (SDTC) is significantly increased in IEM patients (Fig. 5B). The increase appears to be smaller but remains significant with local cooling. The threshold elevation at hyperpolarizing threshold electrotonus (TE) during the late period (50–100 ms) is significantly reduced in IEM patients (Fig. 5C). Interestingly, this reduction is mostly ameliorated by local cooling (e.g., threshold reduction in both TEh(90–100ms) and TEh(99ms) in Table 1). The current–threshold relationship (IV) curves also show similar increase in inward rectification with hyperpolarization preconditioning in IEM patients at baseline (threshold reduction in IV−80% and IV−100% in Table 1). The difference of the threshold changes after preconditioned hyperpolarization, once again, becomes less prominent with cooling (Fig. 5D and Table 1). The indices of recovery cycle (RC) test demonstrated the significantly reduced superexcitability and a trend of increased refractoriness in IEM patients, especially with short (<10 ms) interpulse intervals and cooling (Fig. 5E). These findings lend a further support that there is a deranged recovery kinetics from inactivation in mutant Nav1.7 channels, and cooling could especially slow the recovery and increase of refractoriness in the mutant channels, resulting in an ameliorating effect on IEM symptoms (see Discussion).
Our current works focus on the molecular pathogenesis of heat–exacerbated pain in IEM. Hyperpolarization shift of activation curve and increased window current have long been considered as key contributors of neural hyperexcitability in IEM3. However, most biophysical properties of these mutants have been obtained in room temperature17,18,19, and the temperature effects on these properties have been incongruent across different mutants7,11. To prevent overemphasis on properties in a particular mutant, we carefully seek common properties in three mutants, p.I136V, p.I848T and p.V1316A, which are in different domains of Nav1.7. The major findings are summarized in Table 2.
In our data, heating does not cause further hyperpolarizing shift in all mutants, and even ameliorated the hyperpolarizing shift of activation curve in p.I136V and p. I848T (Fig. 2), while temperature change induces a bimodal increase of window current at higher and lower temperatures (Fig. 2). These in vitro data indicate that the steady–state sustained window currents are probably not decisive for the genesis of rapid repetitive discharges and thus the clinical symptoms upon heating. In contrast, the increase in relative resurgent currents at 40 °C is chiefly due to the decreased peak currents because of the accelerated inactivation. Although the absolute peak seems to be reduced at 40 °C than at 25 °C and 15 °C, the excitability of the cell is increased rather than decreased at 40 °C because the kinetics of the Na+ currents are accelerated (Fig. 3H–J). In other words, the more rapid onset of the transient as well as resurgent Na+ currents (and thus the shorter time to peak) would shorten the time of bringing the membrane potential to the threshold for firing an action potential. The larger relative resurgent currents (relative to the transient currents even it is chiefly due to the smaller transient currents), with a shortened time to peak, therefore should still make a valid signal of increased excitability. On the other hand, the activation curve of resurgent currents and the kinetics of genesis of the inactivated states during the depolarization prepulse in different temperatures are rather similar for the WT and mutant channels (Figs S4 and S5). These findings indicate that the altered kinetics (or more precisely, altered temperature dependence of the kinetics) of the molecular transitions directly related to the genesis of resurgent current are the key factor contributing to the pathogenesis of heat–induced pain in IEM. The prominent increase of relative resurgent currents at 40 °C, based on a slower dissipation and/or faster genesis of the resurgent currents in the mutant channels, would acceleratedly supply the resurgent Na+ currents at higher temperatures and thus aggravate clinical symptoms with heating.
We also explored the biophysical abnormalities with clinical electrophysiological test. Despite of the small number of cases, the NET study in IEM patients consistently shows decrease in the threshold elevation at the hyperpolarizing TE at 50–100 ms (TEh(50–100ms)), increase of inward rectification in the current–voltage (I/V) curve, and increase of refractoriness at relatively short interpulse interval at 2–6 ms during RC (Fig. 5 and Table 2; c.f.15). Recently, the microneurography study on the C–fiber recovery cycle shows a significant increase of refractoriness in the mechanosensitive and sympathetic fibers from an IEM patient with p.I848T mutation, which is in line with our NET findings13. On the other hand, there is no significant difference in the stimulus–response curve, resting threshold, or the rheobase by temperature changes. These results show the essentially normal axonal excitability in IEM if assessed by single (or unpreconditioned) stimulus, but abnormalities in those NET indices obtained with preceding or preconditioning pulses. These findings could implicate abnormal gating kinetics relevant to inactivation or recovery from inactivation in the mutant Nav1.7 channels. Nevertheless, the case number is small in our current study. Further investigation with a bigger cohort may provide more definitive conclusions.
Albeit the IEM–causing mutations are scattered in different domains of the α–subunit of Nav1.7 channel, the clinical features are rather similar among IEM patients and thus indicate a relatively common functional disturbance among the mutant channels. As discussed in the previous section, the temperature–dependent changes in the resurgent current are similar in different mutant channels and show a tendency well consistent with the clinical features. Although it was argued that IEM–causing mutations (p.I848T and p.L858H in the study) did not affect resurgent Na+ current16, our previous study has shown unambiguous changes in resurgent Na+ current of p.V1316A mutant channel, a mutation causing prototypical IEM14. The discrepancy is probably partly ascribable to the different pulse protocols. The prepulse for the elicitation of the transient currents and subsequent resurgent pulse was set to +20 mV for 20 ms16. However, we have shown that the resurgent Na+ currents actually get smaller with longer prepulses, so that there could be a marked decrease of the currents with a +20 mV × 20 ms pulse14). We therefore chose a stronger and shorter prepulse in our studies (e.g. +40 mV for 10 ms) to check the resurgent currents in a more complete fashion. The stronger temperature dependence in both macroscopic inactivation rate and rate of recovery from inactivation at −80 mV (Fig. 4) in the mutant channels also directly demonstrate the altered channel inactivation as well as the recovery process from inactivation. All these findings on the temperature–dependent molecular gating behavior could be well simulated with a gating scheme (Fig. 6A,B; Supplementary Data Fig. S7), in which the major difference between WT and the mutant channels is in the Q10 of the O2 to I2 transitions (~2 and ~3 for the WT and mutant channels, respectively; Table 3). In other words, the overall recovery kinetics from inactivation are very much temperature–dependent at this temperature range in the mutant channels. Because the overall recovery from inactivation is composed of the recovery via both silent and resurgent routes, it is plausible that at a certain low temperature (e.g. 15 °C), the overall recovery is still slower in the mutant channel but the time to peak is already quite similar between the WT and mutant channels. In contrast, at a higher temperature (e.g. 25 °C), the overall recovery is comparable in the WT and mutant channels, but the time to peak now tends to be shorter in the mutant channels. The temperature–dependent changes in resurgent currents, which are generated during the recovery of the inactivated sodium channel from a previous pulse, may well affect the timing of the genesis of the following discharge and therefore explain the occurrence of paroxysms of repetitive or burst discharges with episodic symptomatic aggravation of IEM (see below).
A characteristic and congruent change among different mutations is the paradoxically increase of resurgent current at higher temperature. Although the resurgent current at lower temperature (15 °C) is increased in both WT and mutant channels, the difference in between is much reduced as compared to that found at 40 °C. Both the experimental data and the computer simulation strongly suggest that the altered transitional rates between O2 and I2 states (Fig. 6B and Table 3) play a major role in the genesis of the deranged resurgent currents in IEM. Interestingly, the absolute differences in these transitional rates could be minimal or even negligible between WT and mutant channels at lower temperatures (such as 15 °C). However, if the Q10 of the designated transitions is changed from ~2 (in the WT) to ~3 (in the mutant channels, Fig. 6 and Table 3), a marked difference of resurgent currents occurs at 40 °C. Thermodynamically speaking, such a change in Q10 signals an activation energy change from 1.1 to 0.69 RT when the temperature is elevated by 10 °C. Also, this energy difference is most likely due to the change in entropy to suffice the altered temperature dependence or Q10. It is consistent with the view that the genesis of resurgent currents involves large–scale conformational changes of the channel protein, most likely involving the changes in multiple hydrophobic bonding, rather than a simple competition between two pore blockers (e.g. the inactivating peptide and the “resurgent” particle)14, which also explains why the point mutations dispersed over different domains in the channel could cause the similar gating changes as well as the similar temperature-dependent symptomatology. With homology modeling of the human Nav1.7 channel (Fig. 7), it is also noted that the p.I136V, p.I848T, and, p.V1316A mutations all increase the inter-residue distances between these mutant residues and the methionine (M1574) in the “IFM” motif which is critical for channel inactivation20,21,22,23,24,25. The conformational changes associated with p.I136V, p.I848T, and, p.V1316A mutations may thus involve imperative machineries of channel inactivation, and alter the processes of recovery from inactivation as well as genesis of resurgent currents. Given the possibility that the key factor for the symptomatic pathogenesis of IEM is the abnormally enhanced and “accelerated” resurgent currents in the mutant Nav1.7 channels, the search for an effective gating modifier in this regard may be a rewarding and fundamental approach for a successful pharmacotherapy of this excruciating disorder.
Materials and Methods
Mutagenesis and expression of DNA constructs of Nav1.7 channel
The full–length cDNA of WT human Nav1.7 channel (SCN9A gene) was purchased from OriGene Technologist (Rockville, MD, USA) and subcloned into pTracer–EF/V5–His vector14. The sequence encoding green fluorescence protein (GFP) was cloned by a separate promoter in the pTracer–EF/V5–His vector. For mutagenesis, cDNA of mutant channels (p.I136V, p.I848T, and p.V1316A) was created using QuikChange Site–Directed Mutagenesis System kits (Stratagene, La Jolla, CA, USA). The identity of each mutant channel was confirmed by automatic DNA sequencing (3730xl DNA Analyzer; Applied Biosystems, Foster, CA, USA) in the third common laboratory of National Taiwan University Hospital.
Preparation of CHO−K1 cell line for DNA transfection
Chinese hamster ovary (CHO−K1) cells, obtained from the Food Industry Research and Development Institute (Hsinchu, Taiwan), were maintained under humidified conditions of 5% CO2/95% O2 at 37 °C in F12−K medium (Thermo Fisher Scientific Inc., USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific Inc., USA) and 1% penicillin–streptomycin–ampicillin antibiotics (PSA; Thermo Fisher Scientific Inc., USA)14. A total of 0.5–1.0 × 106 CHO−K1 cells were seeded onto a 3.5 cm culture dish (Greenpia Technology Inc., South Korea) the day before DNA transfection using Lipofectamine™ 3000 (Thermo Fisher Scientific Inc., USA). For electrophysiological recordings, the CHO−K1 cells were suspended with 0.5 mg/ml trypsin (Sigma Chemical Co., St Louis, MO, USA) and plated on glass cover–slips under conditions of 5% CO2/95% O2 at 37 °C for 10 min before wash–off of trypsin with phosphate–buffered saline.
Electrophysiological recording of CHO−K1 cells expressing DNA constructs
The electrophysiological recording of CHO−K1 cells was performed 48–72 h after DNA transfection. Whole–cell patch clamp recordings for the cell expressing WT and different mutant channels were carried out using with an Axopatch 200A amplifier and pClamp 6.0 software (Axon Instruments, Inc., Sunnyvale, CA, USA). The recorded currents were digitized at a rate of 50 kHz after passing through a low–pass Bessel filter at 10 kHz through a Digidata 1200A interface (Axon Instruments, Inc., Sunnyvale, CA, USA). A pipette with an internal tip diameter of 0.5–1.0 μm was pulled from borosilicate micropipettes (Sutter Instrument, Inc., CA, USA) using a puller (Zeitz Instrument Inc., Martinsried, Germany). The pipette resistance was 1.5–2.5 mΩ when filled with an intracellular solution containing 75 mM CsCl, 75 mM CsF, 5 mM HEPES, 2 mM CaCl2, and 2.5 mM EGTA, titrated by 1.0 M CsOH to pH 7.4. The whole–cell configuration was formed in an extracellular solution 145 mM NaCl, 10 mM HEPES, 2 mM CaCl2, and 2.5 mM MgCl2 titrated by 1.0 M NaOH to pH 7.4. The cell was moved in front of a linear array of pipes (Drummond Scientific Co., Broomall, USA) emitting different extracellular solution. Unless otherwise specified, a short peptide of Navβ4 peptide (KKLITFILKKTREK–OH, 0.1 mM) corresponding to the C–terminal half of the full sequence of the Navβ4 subunit, was added to the intracellular solution and allowed to diffuse into the CHO–K1 cells until response were stable for about 3 min before every experiment. The tetrodotoxin–sensitive (TTX–s) and resurgent currents were determined by subtraction of the currents following 1.0 μM TTX (Tocris, Cookson, Langford, UK).
Effect temperature on the WT and different mutant channel
To evaluate the effects of temperature on the transient and resurgent currents of WT and mutant channels, we exercised temperature control at 15 °C, 25 °C, and 40 °C using an automatic temperature controller (TC–324B and TC–324C; Warner Instruments Corporation, USA). The flow rate of external solution was 0.3 ml/min and the volume of the recording chamber was approximately 5 ml. The recording chamber was maintained at 15 °C, 25 °C, and 40 °C for at least 3 min to ensure homogeneity of the temperature control, which was also confirmed by direct measurement of the external solutions emitted from pipes with appropriate sensors.
Construction of the activation and inactivation curves for WT and mutant Nav1.7 channels
To determine the current–voltage (I–V) relationship, cells were held at −120 mV and subjected to various test pulses increasing in 5 mV increments from −160 to +40 mV for 100 ms. The inter-sweep interval was 1.5 sec. The maximal amplitude of sodium inward currents was plotted as a function of test voltage to generate the I–V plot, including a regression line between + 10 and +40 mV. The reversal potential of sodium was determined by extrapolating the regression line to the transverse axis, and peak sodium conductance (Gmax) was obtained from the slope of this line. Normalized sodium conductance was defined as Ipeak/[(V − VNa+) × Gmax], where Ipeak and V denote peak sodium amplitude and test voltage during different depolarizations, respectively. The normalized sodium conductance was plotted against the membrane voltage, and then fitted with a Boltzmann function: G/Gmax = 1/[1 + exp(Vh − V)/k)], where k is the slope factor, Gmax is peak Na+ conductance, Vh is the potential at half–maximal activation, and V is the membrane voltage, to make the activation curve. For the steady–state inactivation curve of sodium currents, the peak amplitude at a +10 mV test pulse was documented after a 100 ms prepulse at different membrane voltages from a holding potential of −120 mV14. The peak current at the test pulse was normalized to the maximal one (I/Imax) and plotted against the prepulse membrane voltage to construct the inactivation curve. The inactivation curve was then fitted with a Boltzmann function: I/Imax = 1/[1 + exp(V − Vh)/k)], where k is the slope factor, Imax is maximal peak current, Vh is the potential at half–maximal inactivation, and V is the prepulse membrane voltage14,26,27,28,29,30,31. The fittings to the activation and inactivation experimental data sets were performed using Origin 6.0 software (Microcal Software, Inc., Northampton, MA, USA). The area of windows currents was based on the activation and inactivation curves in the WT and different mutant channels, and derived using the Sigmaplot 10.0 (Systat Software. Inc.).
Clinical profile and Nerve excitability test (NET)
All patients and healthy controls were recruited from the Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan, and had provided the written informed consent. All procedures were approved by the Research Ethics Committee of National Taiwan University Hospital (201610049RINB), Taipei, Taiwan. We have followed approved procedures and ethical guidelines by declaration of Helsinki. Patients who harbor a Nav1.7 channel (SCN9A gene) mutation and meet the following clinical criteria were recruited: (1) redness, warmth, and pain in both legs; (2) symptomatic exacerbation by warmth and exercise; (3) relief of symptoms by local cooling; (4) lacking of a secondary cause such as myeloproliferative disease, diabetes, infection, connective tissue diseases, or paraneoplastic syndrome32,33. The patients were asked to document the SF–36 Health Survey Questionnaire regarding the clinical conditions both in summer (July) and in winter (January) seasons34. All subjects received NET in the sensory axons of the left median nerve (detailed procedures in previous studies35). In brief, the stimulation was delivered by an isolated linear bipolar stimulator, DS5 (Digitimer, Welwyn Garden City UK), which was triggered by a computerized software QTRACS (Institute of Neurology, London, UK). According to the TRONDNF protocol (Version 18/8/2008, copyright, Prof. Hugh Bostock, Institute of Neurology, London), each session included five stimulation protocols, including stimulus–response (SR) curve, strength–duration (SD) relationship, threshold electrotonus (TE), current–threshold (I/V) relationship, and recovery cycle (RC)36,37. The target threshold was set at 40% of the amplitude of maximal sensory action potential (SAP) amplitude. Although the feet are usually more affected by the symptoms of pain, local edema and ulcers commonly existed. We therefore chose upper limb for examination. All NET procedures were repeated twice at normal body (~35 °C) and at a cooled skin temperature (10 °C lower than patient’s baseline by local ice packing). Skin temperature was frequently monitored during the examination, and heating with a warm light would be applied to restore the designated temperature if necessary. For analysis, the results of indices were extracted by QTRACP program (Institute of Neurology, London). At RC test, the refractoriness is defined by threshold change measured at an inter–stimulus interval of 2.5 ms for baseline, but of 3.2 ms for cooling because some subjects showed absolute inexcitability at 2.5 ms.
Numerical simulation of resurgent currents and the results of NET
The Markov model for resurgent sodium current was adopted and modified from our previous study14. Q–matrix method was employed to accelerate the computation in simulating voltage–clamp study and NET. Parameters such as activation– and inactivation–curves, peak resurgent currents, time to peak resurgent current, resurgent activation curves and decay of resurgent current, were adjusted to fit the experimental results. For simulation of voltage–clamp recordings, the ionic currents were assumed to have Ohmic relationship, and the reversal potential was set to +100 mV. The derived model from voltage–clamp study was then used to simulate the findings from NET. A mathematical model for human myelinated axon was modified from Bostock’s model, with modifications in the current conductance, pump current and voltage dependence of HCN currents. Because the Hodgkin–Huxley type kinetics for sodium current in the original Bostock’s model has disregarded the occurrence of resurgent currents, we applied the Markov model of sodium channel to simulate resurgent currents38,39. Specifically, twenty–seven percent of transient sodium conductance was replaced by Markov model for resurgent sodium current, according to the percentage of Nav1.7 expressed on peripheral axons40. The detailed equations of mathematical model for human myelinated axon were listed in supplementary data. The time–step was set to 10−3 ms. The computation was performed by MATLAB R2015 suite (The MathWorks, Inc. US).
Homology modeling of the human Nav1.7 channel
A homology model of the human Nav1.7 channel encoded by the SCN9A gene was built according to coordinates acquired from the X-ray crystal structure data of the human voltage-gated Na+ channel Nav1.7 (human Nav1.7; PDB code: 6J8H)41. Homology modeling was performed in a manner similar to that described in previous studies14,42,43,44,45. The amino acid sequence of the human Nav1.7 channel was obtained from the UniProt database (Q15858)14. The complete sequences of the three interdomain linkers of the human Nav1.7 channel (DI-DII linker, C740–P789; DII-DIII linker, M1190–Y1239; and DIII-DIV linker, D1447–V1519) were inserted into the corresponding positions between different domains (DI–DIV) according to a template of the structure of the human Nav1.7 channel14. Aligned sequences were then processed using the Discovery Studio 2018 client software to generate the secondary structure and to assign the relative positions of the human Nav1.7 channel14,42,43,44,45. The conformation with the lowest free energy potential determined using the Discrete Optimized Protein Energy score was chosen for further analysis14,42,43,44,45.
Experimental design and statistical analysis
Data were presented as mean ± standard error of mean (S.E.M.) with sample size, n, indicating the number of cells from which each dataset was collected. Error bars represent S.E.M. The statistical significances were assessed using one–way ANOVA (Figs 1, 2, and Supplementary Data Figs S1 and S3), Kruskal–Wallis test (Fig. 3), and two–way ANOVA (Fig. 4, and Supplementary data Fig. S6), the Mann–Whitney U test for two independent samples (Fig. 5), with a statistically significant level of p < 0.05. Data analyses were performed using the SPSS 20.0 Statistics (New York; United states).
All data generated or analyzed during this study are included in this published article and its Supplementary Information files.
Cox, J. J. et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444, 894–898, https://doi.org/10.1038/nature05413 (2006).
Cox, J. J. et al. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat 31, E1670–1686, https://doi.org/10.1002/humu.21325 (2010).
Lampert, A., Eberhardt, M. & Waxman, S. G. Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents. Handbook of experimental pharmacology 221, 91–110, https://doi.org/10.1007/978-3-642-41588-3_5 (2014).
Waxman, S. G. & Dib-Hajj, S. Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 11, 555–562, https://doi.org/10.1016/j.molmed.2005.10.004 (2005).
Babb, R. R., Alarcon-Segovia, D. & Fairbairn, J. F. 2nd Erythermalgia. Review of 51 Cases. Circulation 29, 136–141 (1964).
Littleford, R. C., Khan, F. & Belch, J. J. Impaired skin vasomotor reflexes in patients with erythromelalgia. Clin Sci (Lond) 96, 507–512 (1999).
Wu, M. T., Huang, P. Y., Yen, C. T., Chen, C. C. & Lee, M. J. A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers. PLoS One 8, e55212, https://doi.org/10.1371/journal.pone.0055212 (2013).
Eberhardt, M. et al. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation. J Biol Chem 289, 1971–1980, https://doi.org/10.1074/jbc.M113.502211 (2014).
Estacion, M. et al. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 28, 11079–11088, https://doi.org/10.1523/JNEUROSCI.3443-08.2008 (2008).
Tan, Z. Y. et al. Protein kinase C enhances human sodium channel hNav1.7 resurgent currents via a serine residue in the domain III-IV linker. FEBS Lett 588, 3964–3969, https://doi.org/10.1016/j.febslet.2014.09.011 (2014).
Han, C. et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Molecular pain 3, 3, https://doi.org/10.1186/1744-8069-3-3 (2007).
Lee, M. J. et al. Characterization of a familial case with primary erythromelalgia from Taiwan. Journal of neurology 254, 210–214, https://doi.org/10.1007/s00415-006-0328-3 (2007).
Namer, B. et al. Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7. Pain 156, 1637–1646, https://doi.org/10.1097/j.pain.0000000000000229 (2015).
Huang, C. W., Lai, H. J., Huang, P. Y., Lee, M. J. & Kuo, C. C. The Biophysical Basis Underlying Gating Changes in the p.V1316A Mutant Nav1.7 Channel and the Molecular Pathogenesis of Inherited Erythromelalgia. PLoS biology 14, e1002561, https://doi.org/10.1371/journal.pbio.1002561 (2016).
Farrar, M. A., Lee, M. J., Howells, J., Andrews, P. I. & Lin, C. S. Burning pain: axonal dysfunction in erythromelalgia. Pain 158, 900–911, https://doi.org/10.1097/j.pain.0000000000000856 (2017).
Theile, J. W., Jarecki, B. W., Piekarz, A. D. & Cummins, T. R. Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navbeta4 peptide-mediated resurgent sodium currents. J Physiol 589, 597–608, https://doi.org/10.1113/jphysiol.2010.200915 (2011).
Cummins, T. R., Dib-Hajj, S. D. & Waxman, S. G. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 24, 8232–8236, https://doi.org/10.1523/JNEUROSCI.2695-04.2004 (2004).
Harty, T. P. et al. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J Neurosci 26, 12566–12575, https://doi.org/10.1523/JNEUROSCI.3424-06.2006 (2006).
Cheng, X., Dib-Hajj, S. D., Tyrrell, L. & Waxman, S. G. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade. Molecular pain 4, 1, https://doi.org/10.1186/1744-8069-4-1 (2008).
Lou, B. S., Chen, Y. C. & Wu, H. F. Probing the non-covalent binding interaction of the Na+ channel inactivation gate peptide in a linker between domain III and IV with 5,5-diphenyhydantoin in electrospray ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 21, 3795–3802, https://doi.org/10.1002/rcm.3288 (2007).
McCollum, I. J., Vilin, Y. Y., Spackman, E., Fujimoto, E. & Ruben, P. C. Negatively charged residues adjacent to IFM motif in the DIII-DIV linker of hNa(V)1.4 differentially affect slow inactivation. FEBS Lett 552, 163–169, https://doi.org/10.1016/s0014-5793(03)00912-8 (2003).
Sirota, F. L., Pascutti, P. G. & Anteneodo, C. Molecular modeling and dynamics of the sodium channel inactivation gate. Biophys J 82, 1207–1215, https://doi.org/10.1016/S0006-3495(02)75477-5 (2002).
Miyamoto, K., Kanaori, K., Nakagawa, T. & Kuroda, Y. Solution structures of the inactivation gate particle peptides of rat brain type-IIA and human heart sodium channels in SDS micelles. J Pept Res 57, 203–214 (2001).
Grant, A. O., Chandra, R., Keller, C., Carboni, M. & Starmer, C. F. Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells. Biophys J 79, 3019–3035, https://doi.org/10.1016/S0006-3495(00)76538-6 (2000).
Kuroda, Y. et al. Structural study of the sodium channel inactivation gate peptide including an isoleucine-phenylalanine-methionine motif and its analogous peptide (phenylalanine/glutamine) in trifluoroethanol solutions and SDS micelles. J Pept Res 56, 172–184 (2000).
Ahn, H. S. et al. Differential effect of D623N variant and wild-type Na(v)1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons. Brain Res 1529, 165–177, https://doi.org/10.1016/j.brainres.2013.07.005 (2013).
Cheng, X. et al. Deletion mutation of sodium channel Na(V)1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability. Brain 134, 1972–1986, https://doi.org/10.1093/brain/awr143 (2011).
Han, C. et al. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain 135, 2613–2628, https://doi.org/10.1093/brain/aws187 (2012).
Huang, J. et al. Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons. J Neurosci 33, 14087–14097, https://doi.org/10.1523/JNEUROSCI.2710-13.2013 (2013).
Yang, Y. C., Huang, C. S. & Kuo, C. C. Lidocaine, carbamazepine, and imipramine have partially overlapping binding sites and additive inhibitory effect on neuronal Na+ channels. Anesthesiology 113, 160–174, https://doi.org/10.1097/ALN.0b013e3181dc1dd6 (2010).
Yang, Y. C. & Kuo, C. C. The position of the fourth segment of domain 4 determines status of the inactivation gate in Na+ channels. J Neurosci 23, 4922–4930, doi:23/12/4922 (2003).
Lazareth, I., Fiessinger, J. N. & Priollet, P. Erythermalgia, rare acrosyndrome. 13 cases. Presse Med 17, 2235–2239 (1988).
Thompson, G. H., Hahn, G. & Rang, M. Erythromelalgia. Clin Orthop Relat Res, 249–254 (1979).
McHorney, C. A., Ware, J. E. Jr., Rogers, W., Raczek, A. E. & Lu, J. F. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 30, MS253–265 (1992).
Lai, H. J., Chiang, Y. W. & Lee, M. J. Motor and Sensory Axon Excitability Properties From the Median and Ulnar Nerves and the Effects of Age on These Properties. J Clin Neurophysiol 32, 357–363, https://doi.org/10.1097/WNP.0000000000000172 (2015).
Bostock, H., Cikurel, K. & Burke, D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21, 137–158 (1998).
Kiernan, M. C., Burke, D., Andersen, K. V. & Bostock, H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23, 399–409 (2000).
Kiernan, M. C., Isbister, G. K., Lin, C. S., Burke, D. & Bostock, H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 57, 339–348, https://doi.org/10.1002/ana.20395 (2005).
Howells, J., Trevillion, L., Bostock, H. & Burke, D. The voltage dependence of I(h) in human myelinated axons. J Physiol 590, 1625–1640, https://doi.org/10.1113/jphysiol.2011.225573 (2012).
Black, J. A., Frezel, N., Dib-Hajj, S. D. & Waxman, S. G. Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Molecular pain 8, 82, https://doi.org/10.1186/1744-8069-8-82 (2012).
Shen, H., Liu, D., Wu, K., Lei, J. & Yan, N. Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins. Science 363, 1303–1308, https://doi.org/10.1126/science.aaw2493 (2019).
Huang, C. W. & Kuo, C. C. The bundle crossing region is responsible for the inwardly rectifying internal spermine block of the Kir2.1 channel. Pflugers Arch 466, 275–293, https://doi.org/10.1007/s00424-013-1322-0 (2014).
Huang, C. W. & Kuo, C. C. Gating of the Kir2.1 Channel at the Bundle Crossing Region by Intracellular Spermine and Other Cations. J Cell Physiol 229, 1703–1721, https://doi.org/10.1002/jcp.24616 (2014).
Huang, C. W. & Kuo, C. C. Flow- and voltage-dependent blocking effect of ethosuximide on the inward rectifier K(+) (Kir2.1) channel. Pflugers Arch 467, 1733–1746, https://doi.org/10.1007/s00424-014-1611-2 (2015).
Huang, C. W. & Kuo, C. C. A synergistic blocking effect of Mg2+ and spermine on the inward rectifier K+ (Kir2.1) channel pore. Sci. Rep. 6, 21493, https://doi.org/10.1038/srep21493 (2016).
This work is support by grants MOST107–2321–B–002–012 (to C.-C.K.), MOST106–2320–B–002–014–MY3 (to C.-C.K.), NHRI–EX107–10503NI (to C.-C.K.), and MOST105–2314–B–002–002–MY3 (to M.-J.L.) from National Health Research Institutes, and Ministry of Science and Technology, Taiwan. We thank the third common laboratory, National Taiwan University Hospital for the support of facilities and techniques. Finally, we acknowledge statistical assistance provided by the Center of Statistical Consultation and Research in the Department of Medical Research, National Taiwan University Hospital.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Huang, C., Lai, H., Huang, P. et al. Anomalous enhancement of resurgent Na+ currents at high temperatures by SCN9A mutations underlies the episodic heat-enhanced pain in inherited erythromelalgia. Sci Rep 9, 12251 (2019) doi:10.1038/s41598-019-48672-6